Please try another search
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, which is in a pivotal Phase 2/3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease. The company also develops AN2-502998 (AN15368), an investigational, boron-based small molecule in development for the treatment of chronic Chagas disease that is in preclinical trials. It has a license agreement with Anacor Pharmaceuticals, Inc. to use, develop, manufacture, commercialize, or otherwise exploit certain compounds and products, including epetraborole, for the treatment, diagnosis, or prevention of all human diseases; and Brii Biosciences Limited to research, develop, manufacture, and commercialize certain compounds and products, including epetraborole, in China, Hong Kong, Taiwan, and Macau for the diagnosis, treatment, and prevention of human diseases. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Name | Age | Since | Title |
---|---|---|---|
Patricia A. Martin | 62 | 2021 | Independent Director |
Melvin K. Spigelman | 74 | 2022 | Independent Director |
Margaret M. FitzPatrick | 57 | 2022 | Independent Director |
Kabeer Aziz | 33 | 2019 | Independent Director |
Stephanie Wong | 49 | 2021 | Independent Director |
Gilbert Lynn Marks | 65 | 2020 | Independent Director |
Robin S. Readnour | 59 | 2019 | Independent Director |
Joseph S. Zakrzewski | 61 | 2017 | Co-founder & Chairman of the Board |
Eric E. Easom | 55 | 2019 | Co-founder, CEO, President & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review